Golden Helix Received ISO 13485:2016 Certification
ISO 13485:2016 is an international standard that specifies requirements for a quality management system (QMS) for organizations involved in the design, development, production, and servicing of medical devices. It is specifically tailored to the medical device industry and is recognized globally as a benchmark for ensuring the quality and safety of medical devices.
"We are very pleased to receive ISO 13485:2016 certification. It's a testament to our efforts of continuous quality improvements, including our software development processes, customer success and support processes, and all other operational processes within our company," says Dr.
In order to be certified, an organization has to maintain a quality management system, demonstrate sufficient risk management, and show consistent tracking of customer satisfaction and safety in the market as well as demonstrate continued improvement efforts on the product and system level.
About Golden Helix
Golden Helix has been delivering industry-leading bioinformatics solutions for over a quarter century with thousands of users worldwide. Golden Helix enables hospitals, testing labs, research institutions, and country-wide genome initiatives to conduct a wide spectrum of clinical tests and facilitate genomic research. With its solutions, Golden Helix users can harness the full potential of genomics to identify the cause of disease, gain diagnostic insights, and improve the safety and efficacy of treatments, helping to realize the promise of personalized medicine.
Director of Marketing
Golden Helix, Inc
(406) 551-4901
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/golden-helix-received-iso-134852016-certification-302049993.html
SOURCE Golden Helix Inc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rocket One Accepted into Seagate Partner Program, Expanding AI Infrastructure and Enterprise Data Storage Ecosystem
- Onkos Surgical® Announces 1,000th Personalized My3D® Patient-Specific Pelvic Implant Case
- TIA's DCE 9000 Initiative Builds Momentum with New Members, Expanded Collaboration, and Program Milestones
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share